CAS and Cleveland Clinic: Collaboration announced during the Cleveland Discovery & Innovation Forum. CLEVELAND AND COLUMBUS, Ohio: CAS, a division of the American Chemical Society specializing in scientific content and knowledge...

Next-gen sequencing leader joins microprocessing giant to apply genomics and AI technologies toward drug discovery, clinical research, and human health SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies...

CHICAGO--(BUSINESS WIRE)--Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration...

Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises initial funding from top investors;...

PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...

It enables every actor in Pathology to run digital image analysis in the context of clinical trials, as in CAP/CLIA laboratories, with unprecedented efficiency. This AI-platform strengthens Keen Eye's strategic positioning in the clinical...